Balance Sheet
Accumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RLX Technology (RLX) Cash & Equivalents (2020 - 2025)

Historic Cash & Equivalents for Technology (RLX) over the last 6 years, with Q3 2025 value amounting to $502.4 million.

  • Technology's Cash & Equivalents fell 8456.81% to $502.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $502.4 million, marking a year-over-year decrease of 8456.81%. This contributed to the annual value of $778.4 million for FY2024, which is 13448.5% up from last year.
  • Latest data reveals that Technology reported Cash & Equivalents of $502.4 million as of Q3 2025, which was down 8456.81% from $3.9 billion recorded in Q2 2025.
  • In the past 5 years, Technology's Cash & Equivalents ranged from a high of $9.6 billion in Q1 2021 and a low of $178.4 million during Q4 2022
  • Its 5-year average for Cash & Equivalents is $2.9 billion, with a median of $2.4 billion in 2024.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first skyrocketed by 554696.93% in 2021, then plummeted by 8576.18% in 2022.
  • Quarter analysis of 5 years shows Technology's Cash & Equivalents stood at $814.7 million in 2021, then tumbled by 78.11% to $178.4 million in 2022, then skyrocketed by 86.13% to $332.0 million in 2023, then skyrocketed by 134.56% to $778.7 million in 2024, then tumbled by 35.48% to $502.4 million in 2025.
  • Its Cash & Equivalents was $502.4 million in Q3 2025, compared to $3.9 billion in Q2 2025 and $4.9 billion in Q1 2025.